Breaking News
Get 40% Off 0
💰 Warren Buffett reveals a $6.72 billion stake in Chubb Copy Portfolios
Close

Avadel Pharmaceuticals PLC (AVDL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Avadel Pharma's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
16.090 -0.030    -0.19%
16:00:59 - Closed. Currency in USD ( Disclaimer )
After Hours
16.090
-0.000
-0.000%
18:13:58 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,116,856
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 15.740 - 16.170
Avadel Pharma 16.090 -0.030 -0.19%

Avadel Pharmaceuticals PLC Company Profile

 
Get an in-depth profile of Avadel Pharmaceuticals PLC, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

66

Equity Type

ADR

Avadel Pharmaceuticals plc is a biopharmaceutical company. The Company's lead product candidate, FT218, is an investigational once-nightly, extended-release formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy. Its drug delivery technologies include Micropump, LiquiTime, and Medusa. Its Micropump drug-delivery technology allows for the controlled delivery of small molecule drugs taken orally, which improves dosing compliance, reduces toxicity and improves patient compliance. Its LiquiTime technology allows for development of modified release oral products in a liquid suspension formulation, which makes such formulations particularly well suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of modified-release-injectable dosage formulations of drugs, such as peptides, polypeptides, proteins, and small molecules.

Contact Information

Address 10 Earlsfort Terrace
Dublin, 2
Ireland
Phone 353 1 901 5201
Fax -

Top Executives

Name Age Since Title
Patrick Couvreur - - Member of Scientific Advisory Board
Catherine Bréchignac 75 2011 Chairman of Scientific Advisory Board
Peter J. Thornton 57 2017 Independent Director
Linda S. Palczuk 60 2018 Independent Director
Gregory J. Divis 55 2017 CEO & Director
Jean-Marie Pierre Lehn 83 2005 Member of Scientific Advisory Board
Christian Trepo - 2005 Member of Scientific Advisory Board
Geoffrey M. Glass 48 2018 Independent Non-Executive Chairman of the Board
Mark A. McCamish 69 2019 Independent Director
Eric J. Ende 53 2018 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AVDL Comments

Write your thoughts about Avadel Pharmaceuticals PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Willie Scott
Willie Scott May 09, 2024 1:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My goodness... why is this stock dropping??? They had a good 1st quarter earnings report of 27 million and their drug used has more than doubled... any new insights will be greatly appreciated. thanks
SASHA STARK
SASHA STARK Jun 23, 2023 12:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lawsuit is a joke, will be $20 plus in 2024
Willie Scott
Willie Scott May 11, 2023 8:34PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is it over?
Willie Scott
Willie Scott May 10, 2023 11:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Does anyone think AVDL will surpass 20.oo a share?
Francisco Azevedo e silva
Francisco Azevedo e silva Mar 22, 2023 9:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is happening dudes. Brace yourselves
Francisco Azevedo e silva
Francisco Azevedo e silva Mar 06, 2023 8:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So... what is the bear case? that avadel cant eat market share? Meanwhile it will keep proving doubters wrong
Francisco Azevedo e silva
Francisco Azevedo e silva Nov 30, 2022 12:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Waaaiit let me buy more!
Mr BenDover
Mr BenDover Nov 30, 2022 12:18PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's on fire!
Willie Scott
Willie Scott Oct 05, 2022 2:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's beginning....👀👀
Mr BenDover
Mr BenDover Oct 05, 2022 2:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy out by JAZZ?
Francisco Azevedo e silva
Francisco Azevedo e silva Aug 26, 2022 5:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Once things finaly get going, Avadel will explode. Ten bagger right here
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email